GE Healthcare, LLC CARESCAPE Central Station (CSCS) V2, Model numbers 2082278-001 and 2082279-001. Update 3/10/2023: The following FRU and display part numbers have been added as affected devices: (1) Part #2082294-001, FRU MP200 POWER SUPPLY ASSEMBLY; (2) Part #2082293-002-R, FRU MP200 CPU ASSEMBLY; (3) Part #2082293-002, FRU MP200 CPU ASSEMBLY; (4) Part #2071523-001, MP200 22 IN DISPLAY WITH TOUCH; (5) Part #2092930-001, DSP LCD 22 IN MED W/TCH W/DKST N AMR; (6) Part #2092930-002, DSP LCD 22 IN MED W/TCH W/DK Recall
Check Your Product
According to the U.S. Food and Drug Administration (FDA)
Product
CARESCAPE Central Station (CSCS) V2, Model numbers 2082278-001 and 2082279-001. Update 3/10/2023: The following FRU and display part numbers have been added as affected devices: (1) Part #2082294-001, FRU MP200 POWER SUPPLY ASSEMBLY; (2) Part #2082293-002-R, FRU MP200 CPU ASSEMBLY; (3) Part #2082293-002, FRU MP200 CPU ASSEMBLY; (4) Part #2071523-001, MP200 22 IN DISPLAY WITH TOUCH; (5) Part #2092930-001, DSP LCD 22 IN MED W/TCH W/DKST N AMR; (6) Part #2092930-002, DSP LCD 22 IN MED W/TCH W/DK
Brand
GE Healthcare, LLC
Lot Codes / Batch Numbers
All CARESCAPE Central Station V2 units: (1) CSCS V2 MA1700 Integrated, Product Code SKN, Model #2082278-001, GTIN 00840682109666, (2) CSCS V2 MAS700 Desktop, Product Code SNF, Model #2082279-001, GTIN 00840682109604. NOTE: The Product Code is the first 3 letters of the serial number.
Products Sold
All CARESCAPE Central Station V2 units: (1) CSCS V2 MA1700 Integrated, Product Code SKN, Model #2082278-001, GTIN 00840682109666; (2) CSCS V2 MAS700 Desktop, Product Code SNF, Model #2082279-001, GTIN 00840682109604. NOTE: The Product Code is the first 3 letters of the serial number.
GE Healthcare, LLC is recalling CARESCAPE Central Station (CSCS) V2, Model numbers 2082278-001 and 2082279-001. Update 3/10/2023: due to The CARESAPE Central Station (CSCS) V2 can shut down due to a potential power supply component failure. This can lead to loss of patient monitoring at. Based on FDA medical device recall database.
Summary derived from FDA notice
Reason for Recall
As stated by FDA
The CARESAPE Central Station (CSCS) V2 can shut down due to a potential power supply component failure. This can lead to loss of patient monitoring at the central station.
Recommended Action
Per FDA guidance
The recalling firm issued letters flagged URGENT MEDICAL DEVICE CORRECTION dated 5/10/2022 via traceable means. The letter listed the affected product details and described the safety issue and actions to be taken by the customer/user. It said they can continue to use the CSCS V2 to monitor patients on the CARESCAPE Network. In the event there is a loss of patient monitoring at the CSCS V2, they were to follow the safety instructions, which included: Ensure all patients are adequately monitored using other GE Central Stations, with alternate monitoring devices, or with increased patient surveillance. If additional GE Healthcare Clinical Information Center (CIC) or CARESCAPE Central Station devices are available in the same care unit, unmonitored patients will be automatically assigned to any open, unlocked Multi-Viewer patient windows. If there are not enough Multi-Viewer patient windows, other GE Central Stations in the same care unit will provide a list of unmonitored patients at the top of the Multi-Viewer display. Unmonitored patients can also be viewed on and assigned to any GE Central Station connected to the CARESCAPE Network in a different care unit, and the methods for doing this were described. The customer is referred to the Managing Patients chapter of their Clinical Information Center (CIC) or CARESCAPE Central Station (CSCS) User Manual for more information regarding patient viewing. The letter informed the customer that GE Healthcare will correct all affected products when the correction is available. A Medical Device Notification Acknowledgement Response Required form was enclosed to be completed and returned within 30 days from receipt by scanning or taking a photo of the completed form and emailing it back to the firm. The form is to confirm receipt and understanding of the Correction Notice. UPDATE: On 2/6/2023, the recalling firm issued an amended recall letter dated 2/6/2023 informing the consignee they were now including certain Fi
Verify this information on the official source
For complete details and official instructions, check the U.S. Food and Drug Administration (FDA) directly.
View official FDA recall noticePage updated: Jan 10, 2026